Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Twist Bioscience CorpTWST · Entity 3619 | See Remarks | October 02, 2026 | October 05, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Twist Bioscience Corp
Report date October 02, 2026 · Filed October 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 63,789 |
Reported balance
After 2026-10-02 transaction · row 1
1 source rowRow 1 · 2026-10-02 · Sale · Disposed 9,514 · Balance 63,789 F1: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 11, 2024 Filed Nov 13, 2024 22:24 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 1,507 | $48.00 | $72,332.99 |
DisclosureSEC source: 0001214659-24-018895 · marketforms-67321.xml · nonDerivative · entry 1 Cho Dennis · CIK 0001883451 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 91,163 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| November 06, 2024 Filed Nov 8, 2024 21:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 1,811 | $44.61 | $80,779.66 |
DisclosureSEC source: 0001214659-24-018612 · marketforms-67289.xml · nonDerivative · entry 1 Cho Dennis · CIK 0001883451 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,670 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Performance Stock Units ("PSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| November 06, 2024 Filed Nov 15, 2024 21:05 UTC Amendment | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 1,811 | $44.61 | $80,779.66 |
DisclosureSEC source: 0001214659-24-019255 · marketforms-67364.xml · nonDerivative · entry 1 Cho Dennis · CIK 0001883451 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,670 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Performance Stock Units ("PSUs"). These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| November 04, 2024 Filed Nov 6, 2024 22:06 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 659 | $41.56 | $27,390.68 |
DisclosureSEC source: 0001214659-24-018501 · marketforms-67270.xml · nonDerivative · entry 3 Cho Dennis · CIK 0001883451 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 94,481 F2 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| November 04, 2024 Filed Nov 6, 2024 22:06 UTC | Twist Bioscience Corp TWST · Entity 3619 | GrantCommon Stock | 7,851 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-24-018501 · marketforms-67270.xml · nonDerivative · entry 2 Cho Dennis · CIK 0001883451 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 95,140 F1 · shares: Represents performance stock units for which target criteria was determined to have been met on November 4, 2024. 60% of the PSUs remain subject to time-based vesting and will vest on October 1,2025, subject to continued service or acceleration of vesting as provided in the award agreement. Read SEC document |
| November 04, 2024 Filed Nov 6, 2024 22:06 UTC | Twist Bioscience Corp TWST · Entity 3619 | GrantCommon Stock | 12,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-24-018501 · marketforms-67270.xml · nonDerivative · entry 1 Cho Dennis · CIK 0001883451 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,289 F1 · shares: Represents performance stock units for which target criteria was determined to have been met on November 4, 2024. 60% of the PSUs remain subject to time-based vesting and will vest on October 1,2025, subject to continued service or acceleration of vesting as provided in the award agreement. Read SEC document |
| October 02, 2024 Filed Oct 4, 2024 20:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 3,104 | $43.21 | $134,126.94 |
DisclosureSEC source: 0001214659-24-017189 · marketforms-67119.xml · nonDerivative · entry 1 Cho Dennis · CIK 0001883451 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,289 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| September 20, 2024 Filed Sep 24, 2024 20:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 234 | $46.94 | $10,984.19 |
DisclosureSEC source: 0001214659-24-016671 · marketforms-67031.xml · nonDerivative · entry 1 Cho Dennis · CIK 0001883451 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,393 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| September 16, 2024 Filed Sep 18, 2024 20:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 94 | $46.42 | $4,363.67 |
DisclosureSEC source: 0001214659-24-016521 · marketforms-66997.xml · nonDerivative · entry 1 Cho Dennis · CIK 0001883451 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,627 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| September 06, 2024 Filed Sep 10, 2024 20:04 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 275 | $39.16 | $10,769.28 |
DisclosureSEC source: 0001214659-24-016292 · marketforms-66947.xml · nonDerivative · entry 1 Cho Dennis · CIK 0001883451 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,721 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| August 05, 2024 Filed Aug 7, 2024 20:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 709 | $39.93 | $28,307.53 |
DisclosureSEC source: 0001214659-24-014033 · marketforms-66734.xml · nonDerivative · entry 1 Cho Dennis · CIK 0001883451 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,996 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| July 02, 2024 Filed Jul 5, 2024 20:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 126 | $48.00 | $6,048.25 |
DisclosureSEC source: 0001214659-24-012026 · marketforms-66495.xml · nonDerivative · entry 1 Cho Dennis · CIK 0001883451 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,705 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| June 20, 2024 Filed Jun 24, 2024 20:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 234 | $49.41 | $11,561.94 |
DisclosureSEC source: 0001214659-24-011291 · marketforms-66397.xml · nonDerivative · entry 1 Cho Dennis · CIK 0001883451 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,831 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| June 14, 2024 Filed Jun 18, 2024 20:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 95 | $51.04 | $4,848.41 |
DisclosureSEC source: 0001214659-24-011087 · marketforms-66348.xml · nonDerivative · entry 1 Cho Dennis · CIK 0001883451 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,065 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| June 06, 2024 Filed Jun 10, 2024 20:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 276 | $51.33 | $14,166.80 |
DisclosureSEC source: 0001214659-24-010751 · marketforms-66284.xml · nonDerivative · entry 1 Cho Dennis · CIK 0001883451 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,160 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| May 03, 2024 Filed May 7, 2024 20:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 568 | $37.13 | $21,092.11 |
DisclosureSEC source: 0001214659-24-008524 · marketforms-65754.xml · nonDerivative · entry 1 Cho Dennis · CIK 0001883451 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,436 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| April 02, 2024 Filed Apr 4, 2024 20:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 129 | $32.74 | $4,222.94 |
DisclosureSEC source: 0001214659-24-006123 · marketforms-65453.xml · nonDerivative · entry 1 Cho Dennis · CIK 0001883451 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,004 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| March 20, 2024 Filed Mar 22, 2024 20:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 230 | $33.52 | $7,708.68 |
DisclosureSEC source: 0001214659-24-005019 · marketforms-65308.xml · nonDerivative · entry 1 Cho Dennis · CIK 0001883451 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,133 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| March 14, 2024 Filed Mar 18, 2024 20:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 93 | $34.60 | $3,217.80 |
DisclosureSEC source: 0001214659-24-004695 · marketforms-65221.xml · nonDerivative · entry 1 Cho Dennis · CIK 0001883451 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,363 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| March 06, 2024 Filed Mar 8, 2024 21:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 272 | $37.43 | $10,180.96 |
DisclosureSEC source: 0001214659-24-004247 · marketforms-65107.xml · nonDerivative · entry 1 Cho Dennis · CIK 0001883451 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,456 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. F2 · balance_after: Includes shares that were acquired under the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| February 02, 2024 Filed Feb 6, 2024 21:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 756 | $36.59 | $27,662.04 |
DisclosureSEC source: 0001214659-24-002007 · marketforms-64522.xml · nonDerivative · entry 1 Cho Dennis · CIK 0001883451 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,437 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 21:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 140 | $36.86 | $5,160.40 |
DisclosureSEC source: 0001214659-24-000252 · marketforms-63985.xml · nonDerivative · entry 1 Cho Dennis · CIK 0001883451 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,193 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| December 19, 2023 Filed Dec 21, 2023 21:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 221 | $38.33 | $8,470.93 |
DisclosureSEC source: 0001214659-23-016696 · marketforms-63902.xml · nonDerivative · entry 1 Cho Dennis · CIK 0001883451 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,333 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| December 13, 2023 Filed Dec 15, 2023 21:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 89 | $31.21 | $2,777.69 |
DisclosureSEC source: 0001214659-23-016495 · marketforms-63854.xml · nonDerivative · entry 1 Cho Dennis · CIK 0001883451 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,554 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| December 05, 2023 Filed Dec 7, 2023 21:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 260 | $24.67 | $6,414.20 |
DisclosureSEC source: 0001214659-23-016153 · marketforms-63717.xml · nonDerivative · entry 1 Cho Dennis · CIK 0001883451 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,643 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| November 02, 2023 Filed Nov 6, 2023 21:13 UTC | Twist Bioscience Corp TWST · Entity 3619 | GrantCommon Stock | 29,518 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-23-014603 · marketforms-63443.xml · nonDerivative · entry 3 Cho Dennis · CIK 0001883451 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,903 F3 · shares: Represents a restricted stock unit award ("RSU") of which 1/16th of the total number of RSUs vest on each quarterly anniversary of November 2, 2023 for a total vesting period of 48 months, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| November 02, 2023 Filed Nov 6, 2023 21:13 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 1,918 | $17.31 | $33,200.58 |
DisclosureSEC source: 0001214659-23-014603 · marketforms-63443.xml · nonDerivative · entry 2 Cho Dennis · CIK 0001883451 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,385 F2 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Performance Stock Units ("PSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| November 02, 2023 Filed Nov 6, 2023 21:13 UTC | Twist Bioscience Corp TWST · Entity 3619 | GrantCommon Stock | 13,859 | $20.26 | $280,783.34 |
DisclosureSEC source: 0001214659-23-014603 · marketforms-63443.xml · nonDerivative · entry 1 Cho Dennis · CIK 0001883451 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,303 F1 · shares: Represents performance stock units for which target criteria was determined to have been met on November 2, 2023. 60% of the PSUs remain subject to time-based vesting and will vest on October 1, 2024, subject to continued service or acceleration of vesting as provided in the award agreement. Read SEC document |
| September 29, 2023 Filed Oct 3, 2023 20:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 118 | $20.26 | $2,390.68 |
DisclosureSEC source: 0001214659-23-013060 · marketforms-62720.xml · nonDerivative · entry 1 Cho Dennis · CIK 0001883451 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,444 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| September 19, 2023 Filed Sep 21, 2023 20:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 221 | $20.33 | $4,492.93 |
DisclosureSEC source: 0001214659-23-012534 · marketforms-62653.xml · nonDerivative · entry 1 Cho Dennis · CIK 0001883451 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,562 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| September 13, 2023 Filed Sep 15, 2023 20:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 89 | $23.05 | $2,051.45 |
DisclosureSEC source: 0001214659-23-012386 · marketforms-62592.xml · nonDerivative · entry 1 Cho Dennis · CIK 0001883451 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,783 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| September 05, 2023 Filed Sep 7, 2023 20:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | GrantCommon Stock | 12,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-23-012161 · marketforms-62552.xml · nonDerivative · entry 1 Cho Dennis · CIK 0001883451 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,872 F1 · shares: Represents a restricted stock unit award ("RSU") of which 1/16th of the total number of RSUs vest on each quarterly anniversary of September 5, 2023 for a total vesting period of 48 months, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| June 30, 2023 Filed Jul 5, 2023 20:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 118 | $20.46 | $2,414.28 |
DisclosureSEC source: 0001214659-23-009246 · marketforms-62017.xml · nonDerivative · entry 1 Cho Dennis · CIK 0001883451 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,872 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| June 16, 2023 Filed Jun 21, 2023 20:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 220 | $18.31 | $4,028.20 |
DisclosureSEC source: 0001214659-23-008706 · marketforms-61896.xml · nonDerivative · entry 1 Cho Dennis · CIK 0001883451 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,990 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| June 13, 2023 Filed Jun 15, 2023 20:15 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 87 | $18.55 | $1,613.85 |
DisclosureSEC source: 0001214659-23-008530 · marketforms-61821.xml · nonDerivative · entry 1 Cho Dennis · CIK 0001883451 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,210 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| May 10, 2023 Filed May 12, 2023 20:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | PurchaseCommon Stock | 10,000 | $13.20 | $132,000.00 |
DisclosureSEC source: 0001214659-23-006958 · marketforms-61488.xml · nonDerivative · entry 1 Cho Dennis · CIK 0001883451 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,297 Read SEC document |
| March 31, 2023 Filed Apr 4, 2023 20:30 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 136 | $15.08 | $2,050.88 |
DisclosureSEC source: 0001214659-23-004903 · marketforms-61135.xml · nonDerivative · entry 1 Cho Dennis · CIK 0001883451 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,297 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| March 17, 2023 Filed Mar 21, 2023 20:03 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 255 | $16.51 | $4,210.05 |
DisclosureSEC source: 0001214659-23-004056 · marketforms-60920.xml · nonDerivative · entry 1 Cho Dennis · CIK 0001883451 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,433 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| March 13, 2023 Filed Mar 15, 2023 20:30 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 103 | $16.83 | $1,733.49 |
DisclosureSEC source: 0001214659-23-003849 · marketforms-60798.xml · nonDerivative · entry 1 Cho Dennis · CIK 0001883451 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,688 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). F2 · balance_after: Includes shares that were acquired under the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c) Read SEC document |
| March 13, 2023 Filed Mar 15, 2023 20:02 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 103 | $16.83 | $1,733.49 |
DisclosureSEC source: 0001214659-23-003845 · marketforms-60798.xml · nonDerivative · entry 1 Cho Dennis · CIK 0001883451 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,688 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). F2 · balance_after: Includes shares that were acquired under the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c) Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 21:30 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 136 | $23.81 | $3,238.16 |
DisclosureSEC source: 0001214659-23-000272 · marketforms-57993.xml · nonDerivative · entry 1 Cho Dennis · CIK 0001883451 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,158 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| December 19, 2022 Filed Dec 21, 2022 21:59 UTC | Twist Bioscience Corp TWST · Entity 3619 | GrantCommon Stock | 10,210 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-22-015186 · marketforms-57915.xml · nonDerivative · entry 1 Cho Dennis · CIK 0001883451 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,294 F1 · shares: Represents a restricted stock unit award ("RSU") of which 1/16th of the total number of RSUs vest on each quarterly anniversary of December 19, 2022 for a total vesting period of 48 months, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| December 13, 2022 Filed Dec 15, 2022 21:30 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 89 | $26.46 | $2,354.94 |
DisclosureSEC source: 0001214659-22-014982 · marketforms-57850.xml · nonDerivative · entry 1 Cho Dennis · CIK 0001883451 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,084 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| September 30, 2022 Filed Oct 4, 2022 20:31 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 118 | $35.24 | $4,158.32 |
DisclosureSEC source: 0001214659-22-011989 · marketforms-57253.xml · nonDerivative · entry 1 Cho Dennis · CIK 0001883451 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,173 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| September 13, 2022 Filed Sep 15, 2022 20:35 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 355 | $39.66 | $14,079.30 |
DisclosureSEC source: 0001214659-22-011162 · marketforms-57112.xml · nonDerivative · entry 1 Cho Dennis · CIK 0001883451 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,291 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). F2 · balance_after: Includes shares that were acquired under the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| July 01, 2022 Filed Jul 6, 2022 20:35 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 118 | $37.08 | $4,375.44 |
DisclosureSEC source: 0001214659-22-008656 · marketforms-56622.xml · nonDerivative · entry 1 Cho Dennis · CIK 0001883451 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,167 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 20:35 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 136 | $52.91 | $7,195.76 |
DisclosureSEC source: 0001214659-22-004869 · marketforms-55950.xml · nonDerivative · entry 1 Cho Dennis · CIK 0001883451 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,285 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| January 27, 2022 Filed Jan 31, 2022 21:35 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 136 | $77.39 | $10,525.04 |
DisclosureSEC source: 0001214659-22-001435 · marketforms-55171.xml · nonDerivative · entry 1 Cho Dennis · CIK 0001883451 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,421 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| December 27, 2021 Filed Dec 29, 2021 21:30 UTC | Twist Bioscience Corp TWST · Entity 3619 | GrantCommon Stock | 5,460 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-21-013755 · marketforms-54801.xml · nonDerivative · entry 1 Cho Dennis · CIK 0001883451 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,557 F1 · shares: Represents a restricted stock unit award ("RSU") of which 1/16th of the total number of RSUs vest on each quarterly anniversary of October 1, 2021, for a total vesting period of 48 months, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| September 13, 2021 Filed Sep 16, 2021 20:49 UTC | Twist Bioscience Corp TWST · Entity 3619 | GrantEmployee Stock Option (right to buy) · Derivative | 8,194 | $0.00 Strike: $115.93 | $0.00 |
DisclosureSEC source: 0001214659-21-009570 · marketforms-53812.xml · derivative · entry 2 Cho Dennis · CIK 0001883451 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,194 Underlying: Common Stock · 8,194 shares Expires 2031-09-12 F1 · shares: Represents a restricted stock unit award ("RSU") of which 25% of the total number of RSUs vest on the first anniversary of September 13, 2021 and 1/16th of the total number of RSUs vest on each quarterly anniversary thereafter, for a total vesting period of 48 months, subject to the Reporting Person's continuous service through each vesting date. F2 · derivative.exercise_date: 25% of the shares subject to the option vest and become exercisable on the one (1) year anniversary of September 13, 2021 and 1/48 of the shares subject to the option vest and become exercisable monthly thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.